Is a
Clinical Study attributes
NCT Number
Health Conditions in Trial
Trial Recruitment Size
1000
Trial Sponsor
Clinical Trial Start Date
May 31, 2017
0Primary Completion Date
June 12, 2019
0Study Completion Date
July 11, 2019
0Clinical Trial Study Type
Interventional0
Interventional Trial Purpose
Basic Science0
Intervention Type
Drug0
Intervention Name
LC51-02550
Placebo0
Interventional Trial Phase
Phase 10
Participating Facility
Official Name
A Dose Blocked-randomized, Double-blind, Placebo Controlled, Single and Multiple Dosing, Dose-escalation Phase I Clinical Trial to Investigate the Safety, Tolerability, Pharmacokinetic/Pharmacodynamics and Food Effect of LC51-02550
Last Updated
September 18, 2020
0Allocation Type
Randomized0
Intervention Model
Parallel Assignment0
Masking Type
Double0
Masked Party
Investigator0
Participant0
Study summary
1. To evaluate the safety and tolerability of LC51-0255 in healthy male subjects 2. To evaluate the pharmacokinetic/pharmacodynamics characteristics (PK/PD) of LC51-0255 in healthy male subjects 3. To evaluate bioavailability of LC51-0255
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
